Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Aminopeptidase
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Endogenous Metabolite
    (1)
  • HIV Protease
    (1)
  • Mitophagy
    (1)
  • NF-κB
    (1)
  • Topoisomerase
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

als-i

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | Inhibitors_Agonists
  • Natural Products
    1
    TargetMol | Natural_Products
ALS-I
ALS1,Acid-Liable Surfactant-1,ALS 1,ALS-1
T29909308818-13-5In house
ALS-1 is an acid-Liable surfactant.This compound is unstable in powder form and other related salt forms are recommended.
  • Inquiry Price
3-6 months
Size
QTY
ALS-I-41
T266021369357-99-2
ALS-I-41 is a novel, potent and selective antagonist of oxytocin receptor.
    10-14 weeks
    Inquiry
    Betulinic acid
    Lupatic acid, Betulic acid, ALS-357
    T2830472-15-1
    Betulinic acid (ALS-357) is a pentacyclic lupane-type triterpene derivative of betulin (isolated from the bark of Betula alba, the common white birch) which has antiretroviral, antimalarial, and anti-inflammatory properties, as well as a more recently discovered potential as an anticancer agent, by inhibition of topoisomerase.
    • Inquiry Price
    Size
    QTY
    TargetMol | Citations Cited
    Herbicide safener-4
    T2053353056059-99-2
    Herbicide safener-4 (Compound I-15) is a herbicide safener designed to enhance crop resistance to herbicides without diminishing the herbicidal effects on target weeds. It competitively binds to the ALS active site alongside Mesosulfuron-methyl. In addition, Herbicide safener-4 boosts the activities of glutathione GSH, glutathione-S-transferase GST, cytochrome P450 CYP450, peroxidase (POD), superoxide dismutase (SOD), and acetolactate synthase (ALS) within plants.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
    GDC-0134
    RG-6000, RG6000, RG 6000, GDC0134, GDC 0134
    T2020431637394-01-4
    GDC-0134, a dual leucine zipper kinase (DLK) inhibitor, exhibits brain penetration properties. It inhibits DLK to prevent neuronal degeneration and block JNK activation, potentially treating amyotrophic lateral sclerosis (ALS). It has been assessed in a phase 1 study aimed at treating ALS patients.
    • Inquiry Price
    Size
    QTY